In vitro evaluation of the antibacterial activity of Fluorescein® 0.5% eye drops
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:98 |
|---|---|
| Enthalten in: |
Acta ophthalmologica - 98(2020), 2 vom: 17. März, Seite e260-e261 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bouche, Thibaud [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
0619F35CGV |
|---|
| Anmerkungen: |
Date Completed 25.09.2020 Date Revised 25.09.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/aos.14204 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM299711838 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM299711838 | ||
| 003 | DE-627 | ||
| 005 | 20231225100933.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/aos.14204 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0999.xml |
| 035 | |a (DE-627)NLM299711838 | ||
| 035 | |a (NLM)31359588 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bouche, Thibaud |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In vitro evaluation of the antibacterial activity of Fluorescein® 0.5% eye drops |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.09.2020 | ||
| 500 | |a Date Revised 25.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Anesthetics, Local |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Fluorescent Dyes |2 NLM | |
| 650 | 7 | |a Ophthalmic Solutions |2 NLM | |
| 650 | 7 | |a Tetracaine |2 NLM | |
| 650 | 7 | |a 0619F35CGV |2 NLM | |
| 650 | 7 | |a Procaine |2 NLM | |
| 650 | 7 | |a 4Z8Y51M438 |2 NLM | |
| 650 | 7 | |a benoxinate |2 NLM | |
| 650 | 7 | |a AXQ0JYM303 |2 NLM | |
| 650 | 7 | |a Fluorescein |2 NLM | |
| 650 | 7 | |a TPY09G7XIR |2 NLM | |
| 700 | 1 | |a Auzou, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Daurel, Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Quintyn, Jean-Claude |e verfasserin |4 aut | |
| 700 | 1 | |a Join-Lambert, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Guérin, François |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta ophthalmologica |d 2008 |g 98(2020), 2 vom: 17. März, Seite e260-e261 |w (DE-627)NLM171266315 |x 1755-3768 |7 nnns |
| 773 | 1 | 8 | |g volume:98 |g year:2020 |g number:2 |g day:17 |g month:03 |g pages:e260-e261 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/aos.14204 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 98 |j 2020 |e 2 |b 17 |c 03 |h e260-e261 | ||